Concepta gets CE certification for fertility test product

Writer, Stock Market Wire
Monday, October 29, 2018 - 14:05

Medical self-testing platform developer Concepta said it had received CE-Mark certification for its myLotus branded products for women's fertility.

Gaining the certification was a major milestone, enabling the company to sell the device in the UK market and subsequently across CE-Mark territories, it said.

'We will advise on the timing of the UK launch very shortly,' chairman Matthew Walls said.

At 2:05pm: (LON:CPT) Concepta Plc share price was +0.45p at 3.45p


Related content

Concepta appoints Madeleine Kennedy as CFO

Concepta said it had appointed Madeleine Kennedy as chief financial officer. She replaced Barbara Spurrier.

Maddy Kennedy had previously acted as interim CFO for Ieso...

Fri, 25/10/2019 - 08:44


Castleton Technology warns on growth amid weaker-than-expected revenue in H1

Software provider Castleton Technology warned on profit as weaker-than-expected product and professional services revenue amid a tough comparative hurt growth.

While revenue, earnings (EBITDA)...

Thu, 10/10/2019 - 08:27


Concepta raises £2.3m to fund marketing, working capital needs

Healthcare company Concepta said it had raised £2.3m via a share issue to fund marketing and provide additional working capital.

New shares in the company...

Mon, 08/04/2019 - 14:27


Concepta agrees to supply fertility self-test platform product to Walgreens Boots Alliance

UK healthcare company Concepta said Tuesday it had agreed to supply its fertility and hormone self-test platform product to Walgreens Boots Alliance.

The supply...

Tue, 12/03/2019 - 09:52


Costain awarded connected vehicle technology contract

Infrastructure solutions company Costain said Tuesday it had been awarded a technology contract by Highways England to design, install and implement one of the UK's...

Tue, 21/08/2018 - 08:26